Showing results (91-100 of 223) with videos related to
Sort By:
Pageof 23
Molecular Cancer Research : MCR|June 5, 2019
Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer ModelsAnna Hernández-Prat, Alejo Rodriguez-Vida, Nuria Juanpere-Rodero, et al.Scientific Reports|March 31, 2019
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factorsEduardo Tormo, Sandra Ballester, Anna Adam-Artigues, et al.Lung Cancer (Amsterdam, Netherlands)|August 4, 2020
International real-world study of DLL3 expression in patients with small cell lung cancerFederico Rojo, Marcelo Corassa, Dimitrios Mavroudis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapyEnriqueta Felip, Federico Rojo, Martin Reck, et al.Oncotarget|June 22, 2016
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancerOscar Aguilera, María Muñoz-Sagastibelza, Blanca Torrejón, et al.International Journal of Molecular Sciences|July 24, 2021
A Novel <i>NFIX-STAT6</i> Gene Fusion in Solitary Fibrous Tumor: A Case ReportDavid S Moura, Juan Díaz-Martín, Silvia Bagué, et al.International Journal of Molecular Sciences|February 13, 2025
The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung CancerAlbert Iñañez, Raúl Del Rey-Vergara, Fabricio Quimis, et al.Breast Cancer Research and Treatment|May 2, 2019
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy aloneIvana Sestak, Miguel Martín, Peter Dubsky, et al.International Journal of Molecular Sciences|February 25, 2023
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast CancerSandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano, et al.Current Pharmaceutical Design|June 25, 2016
Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor BiologyMercè Mateu-Jimenez, Clara Fermoselle, Federico Rojo, et al.Pageof 23